Merck | MRK - أصول متداولة





أصول متداولة تغيير تاريخ
Adidas EUR 12.28B 303M 2026-03
Adyen EUR 11.69B 1.7B 2025-12
Akzo Nobel EUR 7.53B 1.47B 2026-03
Alcon AG USD 6.62B 171M 2026-03
Amadeus IT EUR 2.32B 162.6M 2026-03
Amarin USD 626.02M 23.87M 2026-03
AstraZeneca USD 29.61B 890M 2026-03
BASF EUR 31.68B 1.4B 2025-12
Bayer EUR 35.3B 2.39B 2026-03
Beiersdorf EUR 6.66B 8M 2025-12
Covestro EUR 5.91B 259M 2025-12
Danone EUR 13.23B 332M 2025-12
Fresenius EUR 11.03B 1.03B 2025-12
Fresenius Medical Care EUR 8.11B 209.55M 2026-03
Genmab DKK 2.88B 1.59B 2025-12
Givaudan CHF 4.07B 258M 2025-12
GlaxoSmithKline GBP 17.76B 251M 2026-03
GRIFOLS EUR 5.25B 180M 2026-03
Henkel EUR 10.07B 268M 2025-12
Hikma Pharmaceutical USD 2.64B 86M 2025-12
Infineon EUR 10.52B 693M 2026-03
Lakefront Biotherapeutics EUR 3.06B 18.72M 2026-03
Linde USD 13.32B 6M 2025-12
Lonza CHF 8B 3.41B 2025-12
Merck EUR 14.16B 932M 2026-03
Novartis USD 26.61B 3.85B 2026-03
Philips EUR 9.78B 148M 2026-03
Roche Holding CHF 38.73B 3.03B 2025-12
Sanofi EUR 30.16B 789M 2026-03
UCB EUR 6.05B 733M 2025-12